These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10500046)

  • 1. Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass.
    Lazar HL; Bao Y; Gaudiani J; Rivers S; Marsh H
    Circulation; 1999 Sep; 100(13):1438-42. PubMed ID: 10500046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble complement receptor type I limits damage during revascularization of ischemic myocardium.
    Lazar HL; Hamasaki T; Bao Y; Rivers S; Bernard SA; Shemin RJ
    Ann Thorac Surg; 1998 Apr; 65(4):973-7. PubMed ID: 9564912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-bonded circuits decrease myocardial ischemic damage: an experimental study.
    Lazar HL; Zhang X; Hamasaki T; Memmelo CA; Treanor P; Rivers S; Aldea GS; Bernard SA; Shemin RJ
    Ann Thorac Surg; 1997 Jun; 63(6):1701-5. PubMed ID: 9205170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions.
    Lazar HL; Zhang X; Rivers S; Bernard S; Shemin RJ
    Ann Thorac Surg; 1995 Aug; 60(2):411-6. PubMed ID: 7646105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of percutaneous bypass in reducing infarct size after revascularization for acute coronary insufficiency.
    Lazar HL; Yang XM; Rivers S; Treanor P; Shemin RJ
    Circulation; 1991 Nov; 84(5 Suppl):III416-21. PubMed ID: 1934439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining percutaneous bypass with coronary retroperfusion limits myocardial necrosis.
    Lazar HL; Treanor P; Rivers S; Bernard S; Shemin RJ
    Ann Thorac Surg; 1995 Feb; 59(2):373-8. PubMed ID: 7847951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium.
    Weisman HF; Bartow T; Leppo MK; Boyle MP; Marsh HC; Carson GR; Roux KH; Weisfeldt ML; Fearon DT
    Trans Assoc Am Physicians; 1990; 103():64-72. PubMed ID: 2132543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced recovery of ischemic myocardium by combining percutaneous bypass with intraaortic balloon pump support.
    Lazar HL; Treanor P; Yang XM; Rivers S; Bernard S; Shemin RJ
    Ann Thorac Surg; 1994 Mar; 57(3):663-7; discussion 667-8. PubMed ID: 8147638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of leukocyte depletion during cardiopulmonary bypass and cardioplegic arrest.
    Lazar HL; Zhang X; Hamasaki T; Treanor P; Rivers S; Bernard S; Shemin RJ
    Ann Thorac Surg; 1995 Dec; 60(6):1745-8. PubMed ID: 8787474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of infarct size with coronary venous retroperfusion.
    Lazar HL; Haan CK; Yang X; Rivers S; Bernard S; Shemin RJ
    Circulation; 1992 Nov; 86(5 Suppl):II352-7. PubMed ID: 1358475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.
    Gillinov AM; DeValeria PA; Winkelstein JA; Wilson I; Curtis WE; Shaw D; Yeh CG; Rudolph AR; Baumgartner WA; Herskowitz A
    Ann Thorac Surg; 1993 Mar; 55(3):619-24. PubMed ID: 8383955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage.
    Chai PJ; Nassar R; Oakeley AE; Craig DM; Quick G; Jaggers J; Sanders SP; Ungerleider RM; Anderson PA
    Circulation; 2000 Feb; 101(5):541-6. PubMed ID: 10662752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function.
    Pierre AF; Xavier AM; Liu M; Cassivi SD; Lindsay TF; Marsh HC; Slutsky AS; Keshavjee SH
    Transplantation; 1998 Sep; 66(6):723-32. PubMed ID: 9771835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does off-pump revascularization reduce coronary endothelial dysfunction?
    Lazar HL; Bao Y; Rivers S
    J Card Surg; 2004; 19(5):440-3. PubMed ID: 15383057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.
    Weisman HF; Bartow T; Leppo MK; Marsh HC; Carson GR; Concino MF; Boyle MP; Roux KH; Weisfeldt ML; Fearon DT
    Science; 1990 Jul; 249(4965):146-51. PubMed ID: 2371562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x.
    Zacharowski K; Otto M; Hafner G; Marsh HC; Thiemermann C
    Br J Pharmacol; 1999 Nov; 128(5):945-52. PubMed ID: 10556930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest.
    Khan TA; Bianchi C; Voisine P; Feng J; Baker J; Hart M; Takahashi M; Stahl G; Sellke FW
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):602-8. PubMed ID: 15457162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation and inhibition in myocardial ischemia and reperfusion injury.
    Homeister JW; Lucchesi BR
    Annu Rev Pharmacol Toxicol; 1994; 34():17-40. PubMed ID: 8042849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.
    Khan TA; Ruel M; Bianchi C; Voisine P; Komjáti K; Szabo C; Sellke FW
    J Am Coll Surg; 2003 Aug; 197(2):270-7. PubMed ID: 12892811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.